Esperite N.V. (ESP): Sale by Esperite of stake in Cryo-Save South Africa cancelled
Esperite N.V. (ESP): Sale by Esperite of stake in Cryo-Save South Africa cancelled
Amsterdam, The Netherlands – 03 October 2018
read more
Esperite N.V. (ESP): Sale by Esperite of stake in Cryo-Save South Africa cancelled
Amsterdam, The Netherlands – 03 October 2018
read more
Amsterdam, the Netherlands – 16 May 2018
Genoma continues its intercontinental expansion through a partnership with Intercare, a South African healthcare leader.
Geneva, Switzerland – 9th February 2016
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’), the leading international family stem cell bank, and John Daniel Holdings Ltd (Johannesburg Stock Exchange VCM: JDH), a venture capital company and the controlling shareholder of Lazaron Biotechnologies (SA) Ltd, Africa’s first private cord blood stem cell bank, announced today that the companies signed a memorandum of understanding to establish a new stem cell bank joint venture in South Africa.
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’), de toonaangevende internationale familie-stamcelbank, en John Daniel Holdings Ltd (Johannesburg Stock Exchange VCM: JDH), een venture capital onderneming en de controlerend aandeelhouder van Lazaron Biotechnologies (SA) Ltd, de eerste private navelstrengbloed stamcelbank op het Afrikaanse continent, kondigden vandaag aan dat beide bedrijven een Memorandum of Understanding hebben ondertekend voor de oprichting van een nieuwe stamcelbank joint venture in Zuid- Afrika.